# A Phase IB Study Of Oral SCH 66336 Preoperatively In Patients With Head And Neck Squamous Cell Cancer

> **NCT00038584** · PHASE1 · COMPLETED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 37 (actual)

## Conditions studied

- Carcinoma, Squamous Cell
- Cancer of Head and Neck

## Interventions

- **DRUG:** SCH66336

## Key facts

- **NCT ID:** NCT00038584
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-06
- **Primary completion:** 2004-11
- **Final completion:** 2004-11
- **Target enrollment:** 37 (ACTUAL)
- **Last updated:** 2018-10-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00038584

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00038584, "A Phase IB Study Of Oral SCH 66336 Preoperatively In Patients With Head And Neck Squamous Cell Cancer". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00038584. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*